Aurobindo Pharma arm Eugia Pharma B.V incorporates wholly owned subsidiary in Chile
Hyderabad: Aurobindo Pharma Limited has announced that Eugia Pharma B.V, a wholly owned stepdown subsidiary of the Company, has incorporated a new wholly owned subsidiary in Chile by the name of Eugia Pharma Chile SpA.
In a regulatory filing with the BSE, Aurobindo Pharma stated that the newly incorporated entity will focus on expanding its pharmaceutical products business in Chile.
According to the company, Eugia Pharma Chile SpA was incorporated on October 7, 2025, with an initial subscription to the share capital of CLP 1,000,000 (USD 1,050), divided into 100 shares of CLP 10,000 each.
Headquartered in Hyderabad, India, Aurobindo Pharma Ltd. is a global pharmaceutical company with operations spanning active pharmaceutical ingredients (APIs), generics, and biosimilars. CuraTeQ Biologics is its wholly owned subsidiary focused on biosimilars for oncology and other therapeutic areas, enhancing Aurobindo’s footprint in biologics markets in Europe and beyond.
Read also: Aurobindo Pharma arm incorporates new wholly owned subsidiary in Malaysia
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.